OCGN Ocugen, Inc.
Healthcare$1.35+0.00%OpenMarket Cap: $458.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
73.97
P/S
101.59
EV/EBITDA
-7.01
DCF Value
$-0.19
FCF Yield
-13.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-1483.9%
Net Margin
-1605.2%
ROE
-127987.5%
ROA
-126.0%
ROIC
-157.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.5M | 100.0% | $-17.8M | $-19.2M | $— | — |
| Q4 null | $-193.0K | 100.0% | $-17.0M | $-17.7M | $— | — |
| FY null | $4.4M | 45.9% | $-62.9M | $-67.8M | $— | — |
| Q3 null | $1.8M | 100.0% | $-17.6M | $-20.1M | $— | — |
| Q2 null | $1.4M | 100.0% | $-13.8M | $-14.7M | $— | — |
| Q1 null | $1.5M | 100.0% | $-14.5M | $-15.3M | $— | — |
| Q4 null | $764.0K | 100.0% | $-13.8M | $-13.9M | $— | — |
| FY null | $4.1M | 51.5% | $-54.8M | $-54.1M | $— | — |
| Q3 null | $1.1M | 100.0% | $-13.3M | $-13.0M | $— | — |
| Q2 null | $1.1M | 100.0% | $-15.4M | $-15.3M | $— | — |
| Q1 null | $1.0M | 100.0% | $-12.2M | $-11.9M | $— | — |
| Q4 2023 | $6.0M | 100.0% | $-8.6M | $-9.5M | $-0.04 | — |